{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:11:39Z","timestamp":1793232699781,"version":"4.5.0"},"reference-count":152,"publisher":"Centers for Disease Control MMWR Office","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Surveill. Summ."],"DOI":"10.15585\/mmwr.ss7003a1","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T13:53:52Z","timestamp":1620914032000},"page":"1-26","source":"Crossref","is-referenced-by-count":324,"title":["Surveillance of Vaccination Coverage Among Adult Populations \u2014United States, 2018"],"prefix":"10.15585","volume":"70","author":[{"given":"Peng-Jun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Srivastav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Grohskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwako","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen L.","family":"Dooling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Rodriguez-Lainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R1","unstructured":"CDC. Immunization schedules for healthcare professionals. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/vaccines\/schedules"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R2","unstructured":"CDC. Disease burden of influenza. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/flu\/about\/burden\/index.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R3","unstructured":"CDC. ABCs report:Streptococcus pneumoniae, 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/spneu17.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2015.","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R5","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States.","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R6","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.15585\/mmwr.mm6905a4","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years and older\u2014United States, 2019.","volume":"69","author":"Freedman","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R9","unstructured":"CDC. Vaccination coverage among adults in the United States, National Health Interview Survey, 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/pubs-resources\/NHIS-2017.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R10","unstructured":"US Department of Health and Human Services. Immunization and infectious diseases: Objectives. Washington, DC: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion; 2020. http:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases\/objectives"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.amepre.2018.04.050","article-title":"Promoting adult immunization using population-based data for a composite measure.","volume":"55","author":"Shen","year":"2018","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R12","unstructured":"CDC. National Health Interview Survey: NHIS data, questionnaires and related documentation. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/nchs\/nhis\/data-questionnaires-documentation.htm"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R13","unstructured":"CDC. National Health Interview Survey: survey description. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. ftp:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/Dataset_Documentation\/NHIS\/2018\/srvydesc.pdf"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R14","unstructured":"CDC. National Health Interview Survey: survey description. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. ftp:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/Dataset_Documentation\/NHIS\/2017\/srvydesc.pdf"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6501a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2014.","volume":"65","author":"Williams","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6803a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2019\u201320 influenza season.","volume":"68","author":"Grohskopf","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R17","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R18","unstructured":"National Committee for Quality Assurance. The National Committee for Quality Assurance updates quality measures for HEDIS 2019. Washington, DC: The National Committee for Quality Assurance; 2019. https:\/\/www.ncqa.org\/news\/ncqa-updates-quality-measures-for-hedis-2019"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R19","unstructured":"National Committee for Quality Assurance. The National Committee for Quality Assurance: technique updates for HEDIS 2019. Washington, DC: The National Committee for Quality Assurance: 2019. https:\/\/www.ncqa.org\/wp-content\/uploads\/2018\/10\/HEDIS-2019-Volume-2-Technical-Update.pdf"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.15585\/mmwr.mm6434a4","article-title":"Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"64","author":"Kobayashi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R21","unstructured":"US Department of Health and Human Services. Increase the proportion of adults age 19 years or older who get recommended vaccines. Washington, DC: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion; 2019. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/vaccination\/increase-proportion-adults-age-19-years-or-older-who-get-recommended-vaccines-iid-d03"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R22","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices.","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R23","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1001\/archinte.161.22.2702","article-title":"Generalist and subspecialist physicians\u2019 knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey.","volume":"161","author":"Nichol","year":"2001","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R24","first-page":"1","article-title":"Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2165\/11597310-000000000-00000","article-title":"Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.","volume":"72","author":"Gatwood","year":"2012","journal-title":"Drugs"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/aje\/kwp173","article-title":"Influenza vaccination and mortality: differentiating vaccine effects from bias.","volume":"170","author":"Fireman","year":"2009","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.amepre.2016.08.038","article-title":"Influenza vaccination of healthcare personnel by work setting and occupation\u2014U.S., 2014.","volume":"51","author":"Lu","year":"2016","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R28","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/aje\/kwt158","article-title":"Seasonal influenza vaccination coverage among adult populations in the United States, 2005-2011.","volume":"178","author":"Lu","year":"2013","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.amepre.2019.04.007","article-title":"Seasonal influenza vaccination coverage trends among adult populations, U.S., 2010\u20132016.","volume":"57","author":"Lu","year":"2019","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R30","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.15585\/mmwr.mm6738a2","article-title":"Influenza vaccination coverage among health care personnel\u2014United States, 2017\u201318 influenza season.","volume":"67","author":"Black","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R31","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/cid\/ciz676","article-title":"Projected population benefit of increased effectiveness and coverage of influenza vaccination on influenza burden\u2014United States.","volume":"70","author":"Hughes","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R32","unstructured":"US Department of Health and Human Services. Increase the proportion of people who get the flu vaccine every year. Washington, DC: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion; 2018. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/vaccination\/increase-proportion-people-who-get-flu-vaccine-every-year-iid-09"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R33","unstructured":"Community Preventive Services Task Force. The Guide to Community Preventive Services: what works to promote health? Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.thecommunityguide.org"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/003335491412900203","article-title":"Recommendations from the National Vaccine Advisory committee: standards for adult immunization practice.","volume":"129","author":"Orenstein","year":"2014","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R35","article-title":"Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practice (ACIP).","volume":"46","author":"CDC","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R36","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R37","first-page":"1068","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: updated recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"68","author":"CDC","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R38","unstructured":"CDC. ACIP shared clinical decision-making recommendations. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/vaccines\/acip\/acip-scdm-faqs.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R39","unstructured":"CDC. National diabetes statistics report, 2017: Estimates of diabetes and its burden in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https:\/\/www.cdc.gov\/diabetes\/pdfs\/data\/statistics\/national-diabetes-statistics-report.pdf"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R40","unstructured":"CDC. National chronic kidney disease fact sheet, 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https:\/\/www.cdc.gov\/diabetes\/pubs\/pdf\/kidney_factsheet.pdf"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R41","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/cid\/ciz739","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine use on invasive pneumococcal disease among adults with and without underlying medical conditions\u2014United States.","volume":"70","author":"Ahmed","year":"2020","journal-title":"Clin Infect Dis 2020;70:2484"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R42","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine.","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines.","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R44","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1016\/j.vaccine.2019.08.002","article-title":"Ten years of experience with herpes zoster vaccine in primary care- how attitudes and practices have changed and what it may mean for a new zoster vaccine.","volume":"37","author":"Guo","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R45","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1016\/j.vaccine.2018.09.018","article-title":"Primary care physicians\u2019 experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV).","volume":"36","author":"Hurley","year":"2018","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the use of herpes zoster vaccine.","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1370\/afm.1185","article-title":"Vaccines provided by family physicians.","volume":"8","author":"Campos-Outcalt","year":"2010","journal-title":"Ann Fam Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpeds.2018.10.034","article-title":"Association of provider recommendation and human papillomavirus vaccination initiation among male adolescents aged 13\u201317 years\u2014United States.","volume":"206","author":"Lu","year":"2019","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R49","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.vaccine.2017.12.016","article-title":"Association of provider recommendation and offer and influenza vaccination among adults aged \u226518\u202fyears - United States.","volume":"36","author":"Lu","year":"2018","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R50","first-page":"468","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older\u2014Advisory Committee on Immunization Practices (ACIP), 2012.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R51","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1128\/CMR.00003-08","article-title":"Pertussis vaccination for health care workers.","volume":"21","author":"Sandora","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R52","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.","volume":"55","author":"Kretsinger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R53","first-page":"13","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R54","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ajic.2010.10.009","article-title":"Influenza, hepatitis B, and tetanus vaccination coverage among health care personnel in the United States.","volume":"39","author":"Lu","year":"2011","journal-title":"Am J Infect Control"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R55","first-page":"1073","article-title":"Influenza vaccination coverage among health-care personnel\u2014United States, 2010-11 influenza season.","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R56","first-page":"66","article-title":"Adult vaccination coverage\u2014United States, 2010.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R57","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1016\/j.vaccine.2017.04.028","article-title":"Awareness among adults of vaccine-preventable diseases and recommended vaccinations, United States, 2015.","volume":"35","author":"Lu","year":"2017","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R58","first-page":"1302","article-title":"Tetanus and pertussis vaccination coverage among adults aged \u226518 years\u2014United States, 1999 and 2008.","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R59","unstructured":"CDC. Surveillance for viral hepatitis\u2014United States, 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2017surveillance\/index.htm"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R60","unstructured":"CDC. Widespread person-to-person outbreaks of hepatitis A across the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/hepatitis\/outbreaks\/2017March-HepatitisA.htm"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R61","unstructured":"CDC. Multistate outbreak of hepatitis A virus infections linked to pomegranate seeds from Turkey (final update). Atlanta, GA: US Department of Health and Human Services, CDC; 2014. https:\/\/www.cdc.gov\/hepatitis\/outbreaks\/2013\/a1b-03-31\/index.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R62","unstructured":"CDC. Widespread person-to-person outbreaks of hepatitis A across the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/hepatitis\/outbreaks\/2017March-HepatitisA.htm"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R63","unstructured":"CDC. Viral hepatitis and men who have sex with men. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/hepatitis\/populations\/msm.htm"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R64","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R65","doi-asserted-by":"crossref","unstructured":"Yin S, Barker L, Ly KN, Susceptibility to hepatitis A virus infection in the United States, 2007\u20132016. Clin Infect Dis 2020;20:ciaa298.","DOI":"10.1093\/cid\/ciaa298"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R66","doi-asserted-by":"crossref","unstructured":"CDC. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recommend Rep 2020;69(No. RR-5).","DOI":"10.15585\/mmwr.rr6905a1"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R67","first-page":"1080","article-title":"Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"CDC","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R68","unstructured":"CDC. Hepatitis A and international travel. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/hepatitis\/hav\/havfaq.htm#travel"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R69","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.vaccine.2013.03.011","article-title":"Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States.","volume":"31","author":"Lu","year":"2013","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R70","first-page":"317","article-title":"Recommendation of the Immunization Practices Advisory Committee (ACIP): inactivated hepatitis B virus vaccine.","volume":"31","author":"CDC","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R71","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R72","first-page":"1","article-title":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).","volume":"40","author":"CDC","year":"1991","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R73","first-page":"1709","article-title":"Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R75","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jtm.12026","article-title":"Hepatitis B and C infection in international travelers.","volume":"20","author":"Johnson","year":"2013","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R76","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1708-8305.2001.tb00540.x","article-title":"Risks of hepatitis A and B in the traveling public.","volume":"8","author":"Jong","year":"2001","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2310\/7060.2005.00006","article-title":"Vaccines in travel health: from risk assessment to priorities.","volume":"12","author":"Steffen","year":"2005","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R78","unstructured":"Nothdurft HD, Zuckerman J, Stoffel M, Dieussaert I, Van Damme P. Accelerated vaccination schedules provide protection against hepatitis A and B in last-minute travelers. New York, NY: WebMD. https:\/\/www.medscape.com\/viewarticle\/491698"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R79","unstructured":"CDC. Travelers\u2019 health. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2018\/advising-travelers-with-specific-needs\/last-minute-travelers"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R80","doi-asserted-by":"publisher","first-page":"58S","DOI":"10.1016\/j.amjmed.2005.07.018","article-title":"Hepatitis A vaccine in the last-minute traveler.","volume":"118","author":"Connor","year":"2005","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R81","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1708-8305.2002.tb00872.x","article-title":"Ineffectiveness of the current strategy to prevent hepatitis A in travelers.","volume":"9","author":"De Serres","year":"2002","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R82","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/oxfordjournals.aje.a113277","article-title":"Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?","volume":"115","author":"Dienstag","year":"1982","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1017\/S0195941700062457","article-title":"Occupational risk of hepatitis B infection in hospital workers.","volume":"6","author":"Hadler","year":"1985","journal-title":"Infect Control"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R84","first-page":"1","article-title":"CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.","volume":"62","author":"Schillie","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R85","unstructured":"US Department of Labor. Occupational Safety and Health Administration (OSHA): OSHA law and regulations. U.S. Department of Labor, Occupational Safety and Health Administration; 2020. https:\/\/www.osha.gov\/law-regs.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R86","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/003335491312800609","article-title":"Hepatitis B vaccination coverage among health-care personnel in the United States.","volume":"128","author":"Byrd","year":"2013","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R87","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R88","first-page":"69","article-title":"CDC grand rounds: Reducing the burden of HPV-associated cancer and disease.","volume":"63","author":"Dunne","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R89","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R90","unstructured":"CDC. Human papillomavirus (HPV)-associated cancers. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. https:\/\/www.cdc.gov\/cancer\/hpv\/statistics\/cases.htm"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R91","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011.","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R92","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R93","unstructured":"CDC. The Advisory Committee on Immunization Practices (ACIP): summary report, October 27\u201328, 2010, Atlanta, Georgia. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archive\/min-oct10.pdf"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R94","article-title":"Human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2014.","volume":"63","author":"CDC","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R95","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R96","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.15585\/mmwr.mm6549a5","article-title":"Use of a 2-dose schedule for human papillomavirus vaccination\u2014updated recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"65","author":"Meites","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R97","doi-asserted-by":"publisher","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R98","doi-asserted-by":"publisher","first-page":"718","DOI":"10.15585\/mmwr.mm6833a2","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2018.","volume":"68","author":"Walker","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R99","unstructured":"CDC. Standards for adult immunization practice. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https:\/\/www.cdc.gov\/vaccines\/hcp\/adults\/for-practice\/standards\/index.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R100","first-page":"758","article-title":"Influenza vaccination among pregnant women, the 2011\u201312 season.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R101","first-page":"753","article-title":"Influenza vaccination coverage among health-care personnel\u2014the 2011\u201312 season.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R102","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.vaccine.2008.11.077","article-title":"Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.","volume":"27","author":"Lu","year":"2009","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R103","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/00333549111260S206","article-title":"Increasing inner-city adult influenza vaccination rates: a randomized controlled trial.","volume":"126","author":"Humiston","year":"2011","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R104","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1542\/peds.2011-0950","article-title":"Human papillomavirus vaccination series initiation and completion, 2008-2009.","volume":"128","author":"Dorell","year":"2011","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R105","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1542\/peds.2007-0538","article-title":"Parents with doubts about vaccines: which vaccines and reasons why.","volume":"122","author":"Gust","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R106","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jadohealth.2009.02.006","article-title":"Parental response to human papillomavirus vaccine availability: uptake and intentions.","volume":"45","author":"Gerend","year":"2009","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R107","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.vaccine.2016.01.061","article-title":"HPV vaccination coverage of teen girls: the influence of health care providers.","volume":"34","author":"Smith","year":"2016","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R108","unstructured":"CDC. Human papillomavirus (HPV): for clinicians. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https:\/\/www.cdc.gov\/hpv\/hcp\/index.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R109","doi-asserted-by":"publisher","first-page":"S412","DOI":"10.1016\/j.amepre.2015.03.005","article-title":"Racial and ethnic disparities in vaccination coverage among adult populations in the U.S.","volume":"49","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R110","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5993\/AJHB.31.4.10","article-title":"Socioeconomic factors and persistent racial disparities in childhood vaccination.","volume":"31","author":"Wooten","year":"2007","journal-title":"Am J Health Behav"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R111","first-page":"7","article-title":"Reduction of racial\/ethnic disparities in vaccination coverage, 1995-2011.","volume":"63","author":"Walker","year":"2014","journal-title":"MMWR Suppl"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R112","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.amepre.2005.08.012","article-title":"Influenza and pneumococcal vaccination of adults aged > or = 65: racial\/ethnic differences.","volume":"29","author":"Singleton","year":"2005","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R113","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.amepre.2006.06.025","article-title":"The role of attitudes in understanding disparities in adult influenza vaccination.","volume":"31","author":"Lindley","year":"2006","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R114","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1056\/NEJMsa040609","article-title":"Primary care physicians who treat blacks and whites.","volume":"351","author":"Bach","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R115","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.287.10.1288","article-title":"Racial disparities in the quality of care for enrollees in medicare managed care.","volume":"287","author":"Schneider","year":"2002","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R116","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF01321480","article-title":"Differences in physician prevention practice patterns for white and minority patients.","volume":"13","author":"Gemson","year":"1988","journal-title":"J Community Health"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R117","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/aje\/kwr376","article-title":"Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009.","volume":"175","author":"Lu","year":"2012","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R118","first-page":"1","article-title":"Surveillance of influenza vaccination coverage\u2014United States, 2007-08 through 2011-12 influenza seasons.","volume":"62","author":"Lu","year":"2013;","journal-title":"MMWR Surveill Summ"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R119","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jadohealth.2008.10.143","article-title":"Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006.","volume":"44","author":"Jain","year":"2009","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R120","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jadohealth.2006.11.141","article-title":"Meningococcal conjugate vaccine uptake, measured by Michigan\u2019s immunization registry.","volume":"40","author":"Enger","year":"2007","journal-title":"J Adolesc Health"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R121","unstructured":"CDC. Vaccines for Children Program. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/index.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R122","unstructured":"U.S. Census Bureau. Income, poverty, and health insurance coverage in the United States: 2017. Washington, DC: U.S. Census Bureau; 2018. https:\/\/www.census.gov\/newsroom\/press-releases\/2018\/income-poverty.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R123","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.vaccine.2013.04.041","article-title":"Factors associated with human papillomavirus vaccination among young adult women in the United States.","volume":"31","author":"Williams","year":"2013","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R124","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1016\/j.vaccine.2011.03.058","article-title":"Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005-2007.","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R125","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1525-1497.2006.00401.x","article-title":"Racial similarities in response to standardized offer of influenza vaccination: a MetroNet study.","volume":"21","author":"Schwartz","year":"2006","journal-title":"J Gen Intern Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R126","first-page":"1089","article-title":"Acceptance of pneumococcal vaccine under standing orders by race and ethnicity.","volume":"98","author":"Daniels","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R127","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.amepre.2014.12.008","article-title":"Impact of health insurance status on vaccination coverage among adult populations.","volume":"48","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R128","doi-asserted-by":"publisher","first-page":"S455","DOI":"10.1016\/j.amepre.2015.08.014","article-title":"Meeting the challenges of immunizing adults.","volume":"49","author":"Bridges","year":"2015","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R129","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.amjmed.2008.05.005","article-title":"Barriers to adult immunization.","volume":"121","author":"Johnson","year":"2008","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R130","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0749-3797(00)00263-4","article-title":"Barriers to influenza immunization in a low-income urban population.","volume":"20","author":"Armstrong","year":"2001","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R131","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1532-5415.2005.00585.x","article-title":"Factors associated with vaccination of medicare beneficiaries in five U.S. communities: Results from the racial and ethnic adult disparities in immunization initiative survey, 2003.","volume":"54","author":"Winston","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R132","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7326\/M13-2332","article-title":"U.S. physicians\u2019 perspective of adult vaccine delivery.","volume":"160","author":"Hurley","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R133","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2105\/AJPH.93.1.130","article-title":"Intermittent lack of health insurance coverage and use of preventive services.","volume":"93","author":"Sudano","year":"2003","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R134","doi-asserted-by":"publisher","first-page":"636.e1","DOI":"10.1016\/j.amjmed.2015.10.031","article-title":"Uptake of influenza vaccination and missed opportunities among adults with high-risk conditions, United States, 2013.","volume":"129","author":"Lu","year":"2016","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R135","first-page":"492","article-title":"Immunization in the United States: recommendations, barriers, and measures to improve compliance: part 2: adult vaccinations.","volume":"41","author":"Ventola","year":"2016","journal-title":"P T"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R136","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.amepre.2014.08.009","article-title":"Adult vaccination disparities among foreign-born populations in the U.S., 2012.","volume":"47","author":"Lu","year":"2014","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R137","unstructured":"Grieco EM, Acosta YD, de la Cruz GP, The foreign-born population in the United States, 2010. Washington, DC: US Census Bureau; 2012. https:\/\/www2.census.gov\/library\/publications\/2012\/acs\/acs-19.pdf"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R138","unstructured":"Malone N, Baluja KF, Costanzo JM, Davis CJ. The foreign-born population: 2000. Washington, DC: US Census Bureau; 2003. htpps:\/\/www.census.gov\/prod\/2003pubs\/c2kbr-34.pdf"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R139","unstructured":"Pew Hispanic Center. Foreign-born population in the United States statistical portrait; 2011. Washington, DC: Pew Research Center; 2013. https:\/\/www.pewresearch.org\/hispanic\/2013\/01\/29\/2011-statistical-information-on-immigrants-in-united-states"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R140","first-page":"110","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2014.","volume":"63","author":"Bridges","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R141","first-page":"883","article-title":"Global routine vaccination coverage, 2011.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R142","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10903-007-9048-8","article-title":"Timely immunization series completion among children of immigrants.","volume":"10","author":"Buelow","year":"2008","journal-title":"J Immigr Minor Health"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R143","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.amepre.2018.05.011","article-title":"Clinicians\u2019 and pharmacists\u2019 reported implementation of vaccination practices for adults.","volume":"55","author":"Lutz","year":"2018","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R144","unstructured":"CDC. Immunization Information Systems (IIS). Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/vaccines\/programs\/iis\/annual-report-iisar\/2018-data.html"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R145","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1016\/j.vaccine.2013.06.041","article-title":"Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?","volume":"31","author":"Rolnick","year":"2013","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R146","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0749-3797(98)00159-7","article-title":"Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients.","volume":"16","author":"Mac Donald","year":"1999","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R147","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/S0264-410X(02)00700-4","article-title":"Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata.","volume":"21","author":"Zimmerman","year":"2003","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R148","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/irv.12593","article-title":"Validation of self-reported influenza vaccination in the current and prior season.","volume":"12","author":"King","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R149","doi-asserted-by":"publisher","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R150","doi-asserted-by":"publisher","first-page":"591","DOI":"10.15585\/mmwr.mm6919e2","article-title":"Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration\u2014United States, 2020.","volume":"69","author":"Santoli","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R151","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of medical care because of COVID-19\u2013related concerns\u2014United States, June 2020.","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss7003a1-202105130950-R152","unstructured":"CDC. Vaccination guidance during a pandemic. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/vaccines\/pandemic-guidance\/index.html"}],"container-title":["MMWR. Surveillance Summaries"],"original-title":[],"deposited":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T07:39:44Z","timestamp":1672126784000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/70\/ss\/ss7003a1.htm?s_cid=ss7003a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":152,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,5,14]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.ss7003a1","relation":{},"ISSN":["1546-0738","1545-8636"],"issn-type":[{"value":"1546-0738","type":"print"},{"value":"1545-8636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]}}}